Affinage · Plasmodium

PF3D7_1313300

peptidyl-prolyl cis-trans isomerase, putative

Annotated
2026-09-08
14 papers in source corpus 4 papers cited in narrative 4 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

PF3D7_1313300 is annotated as a member of the Plasmodium falciparum cyclophilin family, a group of putative peptidyl-prolyl cis-trans isomerases and/or molecular chaperones assessed collectively by recombinant biochemistry (PMID:22546550, PMID:21549842). In P. falciparum extracts, cyclophilin-attributable PPIase activity is inhibited by cyclosporin A but not FK506 or rapamycin, and the cyclosporin A-bound cyclophilin fraction inhibits calcineurin phosphatase activity in vitro; however, this activity derives from an unresolved cyclophilin mixture and is not specifically assigned to PF3D7_1313300 (PMID:7520696). Across the recombinantly expressed family, only two of eight members showed PPIase activity while all eight showed chaperone activity, but the abstracts do not resolve which activity profile belongs to PF3D7_1313300 individually (PMID:22546550, PMID:21549842). In P. berghei, the ortholog of PF3D7_1313300 was recovered as a candidate interactor of the PP1c/inhibitor-2 phosphatase regulatory complex in both asexual and sexual stages by affinity pulldown-mass spectrometry (PMID:35162991). Beyond family-level membership and this single co-purification, no experiment has directly characterized the enzymatic activity, binding partners, structure, or in-parasite function of PF3D7_1313300 itself in the available corpus.

Mechanistic history

Synthesis pass · year-by-year structured walk · 4 steps
  1. 1994 Medium

    Establishing whether P. falciparum harbors cyclosporin A-sensitive PPIase activity distinguished cyclophilins from FKBPs as the drug-relevant isomerases and linked this activity to calcineurin regulation, but did not resolve which of many cyclophilins was responsible.

    Evidence In vitro PPIase assay with an inhibitor panel and a calcineurin phosphatase inhibition assay on P. falciparum cell-free extracts

    PMID:7520696

    Open questions at the time
    • Activity attributed to an unresolved cyclophilin mixture, not to PF3D7_1313300 specifically
    • No demonstration that PF3D7_1313300 contributes to the calcineurin-inhibitory activity
    • No in-parasite functional assignment
  2. 2011 Low

    Recombinant production of all 11 P. falciparum cyclophilin/cyclophilin-like proteins, including PF3D7_1313300, under a uniform system enabled family-wide folding and cyclosporin A binding comparison, but did not report PF3D7_1313300-specific results.

    Evidence Recombinant expression and purification in E. coli with thermal melt assays for folding and cyclosporin A binding

    PMID:21549842

    Open questions at the time
    • Abstract does not report specific folding or cyclosporin A binding data for PF3D7_1313300
    • No enzymatic characterization
    • No structural model
  3. 2012 Low

    Orthogonal PPIase and chaperone assays across eight recombinant family members showed the family is functionally split (isomerase-active minority, chaperone-active majority), but the specific activity of PF3D7_1313300 was not distinguished.

    Evidence In vitro PPIase activity assay and thermal aggregation prevention chaperone assay on recombinant proteins

    PMID:22546550

    Open questions at the time
    • Whether PF3D7_1313300 is one of the two PPIase-active members is unstated
    • No substrate identity
    • No in-parasite validation of chaperone or isomerase role
  4. 2022 Low

    Interactome mapping of the PP1c/inhibitor-2 phosphatase complex provided the first candidate physiological context for the PF3D7_1313300 ortholog, placing it near a phosphatase regulatory hub across asexual and sexual stages.

    Evidence mCherry-tagged PP1c and I2 affinity pulldown from P. berghei transgenic parasites followed by mass spectrometry

    PMID:35162991

    Open questions at the time
    • Co-purification not validated as a direct physical interaction
    • Shown for the P. berghei ortholog, not P. falciparum PF3D7_1313300 directly
    • Functional consequence of the association is unknown

Open questions

Synthesis pass · forward-looking unresolved questions
  • The direct enzymatic activity, substrates, binding partners, structure, and in-parasite function of PF3D7_1313300 itself remain uncharacterized, as all current evidence is either family-level or from an ortholog co-purification.
  • No member-specific PPIase or chaperone activity established for PF3D7_1313300
  • No genetic knockout/knockdown phenotype in either species
  • No validated direct binding partner for PF3D7_1313300

Mechanism profile

Synthesis pass · controlled-vocabulary classification
Complex memberships
PP1c/inhibitor-2 phosphatase regulatory complex (candidate interactor, P. berghei ortholog) [#3]

Evidence

Reading pass · 4 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
1994 Peptidyl-prolyl cis-trans isomerase (PPIase) activity was detected in P. falciparum extracts; this activity was completely inhibited by cyclosporin A at concentrations above 0.1 µM but not by FK506 or rapamycin, indicating it is attributable to cyclophilin(s), not FKBPs. Additionally, the P. falciparum cyclophilin-containing extract, in combination with cyclosporin A, inhibited the protein phosphatase activity of bovine calcineurin in vitro. In vitro PPIase activity assay on P. falciparum cell-free extracts; in vitro calcineurin phosphatase inhibition assay with parasite extract plus cyclosporin A Biochemical pharmacology Medium 7520696
2012 Among 8 recombinantly expressed P. falciparum cyclophilin family members, only two displayed PPIase (isomerase) activity, while all eight displayed molecular chaperone activity as measured by prevention of thermal aggregation of model substrates. PF3D7_1313300 is one member of this family assessed in this study; the specific activity profile attributed to each individual member is not distinguished in the abstract beyond this family-level summary. Recombinant protein expression in E. coli; in vitro PPIase activity assay; thermal aggregation prevention chaperone assay Molecular and biochemical parasitology Low 22546550
2011 All 11 P. falciparum cyclophilin or cyclophilin-like proteins (including PF3D7_1313300) were produced recombinantly with a C-terminal His6 tag in E. coli using an identical expression system; recombinant proteins were assessed by thermal melt assay for correct folding and cyclosporin A binding, enabling family-wide functional comparisons. Recombinant expression and purification in E. coli; thermal melt assay for folding and cyclosporin A binding Protein expression and purification Low 21549842
2022 Mass spectrometry-based interactome mapping of PP1c (protein phosphatase 1 catalytic subunit) and its inhibitor I2 in P. berghei identified a peptidyl-prolyl cis-trans isomerase (ortholog of PF3D7_1313300) as a candidate interactor of the PP1c/I2 complex in both asexual (schizont) and sexual (gametocyte) stages, suggesting it may be a target of this phosphatase regulatory complex. mCherry-tagged PP1c and I2 affinity pulldown from P. berghei transgenic parasites followed by mass spectrometry International journal of molecular sciences Low 35162991

Source papers

Stage 0 corpus · 14 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
1994 Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin. Biochemical pharmacology 108 7520696
2005 A Plasmodium falciparum FK506-binding protein (FKBP) with peptidyl-prolyl cis-trans isomerase and chaperone activities. Molecular and biochemical parasitology 51 15664653
2015 Immunophilins: Structures, Mechanisms and Ligands. Current molecular pharmacology 46 25986569
1995 Cloning and characterization of a Plasmodium falciparum cyclophilin gene that is stage-specifically expressed. Molecular and biochemical parasitology 37 8577319
2005 Antimalarial effects of macrolactones related to FK520 (ascomycin) are independent of the immunosuppressive properties of the compounds. The Journal of infectious diseases 31 15776382
2003 Cyclosporin-binding proteins of Plasmodium falciparum. International journal for parasitology 31 12906882
2012 A family of cyclophilin-like molecular chaperones in Plasmodium falciparum. Molecular and biochemical parasitology 23 22546550
2011 Overexpression, purification and assessment of cyclosporin binding of a family of cyclophilins and cyclophilin-like proteins of the human malarial parasite Plasmodium falciparum. Protein expression and purification 14 21549842
2015 Protein profiling of mefloquine resistant Plasmodium falciparum using mass spectrometry-based proteomics. International journal of mass spectrometry 10 26869851
2021 A proteomic glimpse into the effect of antimalarial drugs on Plasmodium falciparum proteome towards highlighting possible therapeutic targets. Pathogens and disease 8 33202000
2015 Computational insights into the suicide inhibition of Plasmodium falciparum Fk506-binding protein 35. Bioorganic & medicinal chemistry letters 6 26091727
2015 Molecular docking study of macrocycles as Fk506-binding protein inhibitors. Journal of molecular graphics & modelling 4 25978804
2022 Mapping PP1c and Its Inhibitor 2 Interactomes Reveals Conserved and Specific Networks in Asexual and Sexual Stages of Plasmodium. International journal of molecular sciences 3 35162991
2018 Expression and characterization of functional domains of FK506-binding protein 35 from Plasmodium knowlesi. Protein engineering, design & selection : PEDS 3 31120120